Status:
TERMINATED
Molecular Genetic and Pathological Studies of Anal Tumors
Lead Sponsor:
Stanford University
Conditions:
Rectal Cancer
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Study the Genetics of Anal Cancer
Detailed Description
To determine the status of previously identified anal cancer molecular markers and any correlations with outcome as well as to discover new molecular biomarkers through correlating molecular data with...
Eligibility Criteria
Inclusion
- Patients with anal tumors
- Undergoing surgery for elective colon and rectal surgery
Exclusion
- No other patients other than adult patients with anal cancer or high risk for anal cancer refered to Stanford will be enrolled to the study. No Children will be included to the study
Key Trial Info
Start Date :
September 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00267787
Start Date
September 1 2004
End Date
December 1 2017
Last Update
December 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305